ApprovalTrail

Approval · Notice of Compliance 3329 · 1997

BUSPIRONE: Notice of Compliance 3329

Issued April 15, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3329
Date
April 15, 1997
Company
Prempharm Inc.Etobicoke, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Anxiolytic

Products in this notice

BrandDINStatus today
BUSPIRONE02231000—

Medicinal ingredients